John V Mulcahy

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 4

Top Topics

Neuropathic Pain

Induced Pluripotent Stem Cells

Top Venues

British journal of pharmacology

Journal of medicinal chemistry

ACS medicinal chemistry letters

SiteOne Therapeutics

Stanford University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

SiteOne Therapeutics

United States

Vice President, Research

Education History

Stanford University

United States

PHD :: Chemistry

Publications

John V Mulcahy, Jacob T Beckley, Sheri D Klas, Debra A Odink, Anton Delwig, Hassan Pajouhesh, Dennis Monteleone, Xiang Zhou, Justin Du Bois, David C Yeomans, George Luu, John C Hunter
ST-2560, a selective inhibitor of the Na V 1.7 sodium channel, affects nocifensive and cardiovascular reflexes in non-human primates. British journal of pharmacology 181 (17) (2024)
John V Mulcahy, Jacob T Beckley, Sheri D Klas, Debra A Odink, Anton Delwig, Hassan Pajouhesh, Dennis Monteleone, Xiang Zhou, Justin Du Bois, David C Yeomans, George Luu, John C Hunter
ST-2560, a selective inhibitor of the Na V 1.7 sodium channel, affects nocifensive and cardiovascular reflexes in non-human primates. British journal of pharmacology (2024)
Hassan Pajouhesh, Anton Delwig, Jacob T Beckley, Sheri Klas, Dennis Monteleone, Xiang Zhou, George Luu, Justin Du Bois, John C Hunter, John V Mulcahy
Discovery of Selective Inhibitors of Na V 1.7 Templated on Saxitoxin as Therapeutics for Pain. ACS medicinal chemistry letters 13 (11) (2022)
John V Mulcahy, Hassan Pajouhesh, Jacob T Beckley, Anton Delwig, Justin Du Bois, John C Hunter
Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform NaV1.7. Journal of medicinal chemistry 62 (19) (2019)